Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004))

Mary K. McKenna; Alexander Englisch; Benjamin Brenner; Tyler Smith; Valentina Hoyos; Masataka Suzuki; Malcolm K. Brenner

doi:10.1016/j.ymthe.2021.10.007

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004))

Mary K. McKenna, Alexander Englisch, Benjamin Brenner, Tyler Smith, Valentina Hoyos, Masataka Suzuki, Malcolm K. Brenner

Houston Methodist

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

(Molecular Therapy 29, 1808–1820; May 5,2021) In the originally published version of this article, a reference to Figure 2 was incorrect in the text, and the Figure 3 legend description was reversed for Figures 3E and 3F. The y-axis in Figure 3E was represented as a percentage rather than a fraction. The data remain unchanged. The figure and legend have now been corrected online. The authors regret this error.

Original language	English (US)
Pages (from-to)	3529-3533
Number of pages	5
Journal	Molecular Therapy
Volume	29
Issue number	12
DOIs	https://doi.org/10.1016/j.ymthe.2021.10.007
State	Published - Dec 1 2021

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics
Pharmacology
Drug Discovery

Access to Document

10.1016/j.ymthe.2021.10.007

Fingerprint

Dive into the research topics of 'Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004))'. Together they form a unique fingerprint.

Cite this

McKenna, M. K., Englisch, A., Brenner, B., Smith, T., Hoyos, V., Suzuki, M., & Brenner, M. K. (2021). Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004)). Molecular Therapy, 29(12), 3529-3533. https://doi.org/10.1016/j.ymthe.2021.10.007

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004)). / McKenna, Mary K.; Englisch, Alexander; Brenner, Benjamin et al.
In: Molecular Therapy, Vol. 29, No. 12, 01.12.2021, p. 3529-3533.

Research output: Contribution to journal › Article › peer-review

McKenna, MK, Englisch, A, Brenner, B, Smith, T, Hoyos, V, Suzuki, M & Brenner, MK 2021, 'Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004))', Molecular Therapy, vol. 29, no. 12, pp. 3529-3533. https://doi.org/10.1016/j.ymthe.2021.10.007

McKenna MK, Englisch A, Brenner B, Smith T, Hoyos V, Suzuki M et al. Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004)). Molecular Therapy. 2021 Dec 1;29(12):3529-3533. doi: 10.1016/j.ymthe.2021.10.007

McKenna, Mary K. ; Englisch, Alexander ; Brenner, Benjamin et al. / Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity : Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004)). In: Molecular Therapy. 2021 ; Vol. 29, No. 12. pp. 3529-3533.

@article{2276e460e927414e9ce50b9958024279,

title = "Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004))",

abstract = "(Molecular Therapy 29, 1808–1820; May 5,2021) In the originally published version of this article, a reference to Figure 2 was incorrect in the text, and the Figure 3 legend description was reversed for Figures 3E and 3F. The y-axis in Figure 3E was represented as a percentage rather than a fraction. The data remain unchanged. The figure and legend have now been corrected online. The authors regret this error.",

author = "McKenna, {Mary K.} and Alexander Englisch and Benjamin Brenner and Tyler Smith and Valentina Hoyos and Masataka Suzuki and Brenner, {Malcolm K.}",

note = "Publisher Copyright: {\textcopyright} 2021 The American Society of Gene and Cell Therapy",

year = "2021",

month = dec,

day = "1",

doi = "10.1016/j.ymthe.2021.10.007",

language = "English (US)",

volume = "29",

pages = "3529--3533",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity

T2 - Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004))

AU - McKenna, Mary K.

AU - Englisch, Alexander

AU - Brenner, Benjamin

AU - Smith, Tyler

AU - Hoyos, Valentina

AU - Suzuki, Masataka

AU - Brenner, Malcolm K.

PY - 2021/12/1

Y1 - 2021/12/1

N2 - (Molecular Therapy 29, 1808–1820; May 5,2021) In the originally published version of this article, a reference to Figure 2 was incorrect in the text, and the Figure 3 legend description was reversed for Figures 3E and 3F. The y-axis in Figure 3E was represented as a percentage rather than a fraction. The data remain unchanged. The figure and legend have now been corrected online. The authors regret this error.

AB - (Molecular Therapy 29, 1808–1820; May 5,2021) In the originally published version of this article, a reference to Figure 2 was incorrect in the text, and the Figure 3 legend description was reversed for Figures 3E and 3F. The y-axis in Figure 3E was represented as a percentage rather than a fraction. The data remain unchanged. The figure and legend have now been corrected online. The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=85118347454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118347454&partnerID=8YFLogxK

U2 - 10.1016/j.ymthe.2021.10.007

DO - 10.1016/j.ymthe.2021.10.007

M3 - Article

C2 - 34706248

AN - SCOPUS:85118347454

SN - 1525-0016

VL - 29

SP - 3529

EP - 3533

JO - Molecular Therapy

JF - Molecular Therapy

IS - 12

ER -

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity (Molecular Therapy (2021) 29(5) (1808–1820), (S152500162100071X), (10.1016/j.ymthe.2021.02.004))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this